Caladrius Biosciences Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
46,133.80
26,254.10
20,318.40
7,076.70
60,084.70
43,053
Total Accounts Receivable
1,860.80
3,111.30
2,566.10
138.80
234.50
-
Inventories
1,270.20
-
-
-
-
-
Other Current Assets
1,561.90
4,349.20
3,476.20
17,433.50
790.50
1,053
Total Current Assets
50,826.80
33,714.60
26,360.70
24,649.00
61,109.60
44,106
Net Property, Plant & Equipment
12,844.20
15,960.70
17,064.90
705.40
256.90
165
Intangible Assets
24,993.40
72,769.70
9,891.20
-
-
-
Other Assets
1,151.70
3,830.40
3,888.50
28,160.00
1,434.10
309
Total Assets
89,816.10
126,275.40
57,205.30
53,514.40
63,375.70
44,580
ST Debt & Current Portion LT Debt
594.20
1,926.40
5,364.10
3,690.20
159.20
Accounts Payable
3,354.90
5,661.20
4,107.40
2,226.60
1,343.10
Other Current Liabilities
5,857.80
8,657.00
11,543.70
15,266.10
7,810.90
Total Current Liabilities
9,806.90
16,244.60
21,015.20
21,182.90
9,313.20
Long-Term Debt
3,554.80
14,716.30
11,411.60
2,684.10
-
Provision for Risks & Charges
-
18,260.00
-
-
-
Deferred Taxes
4,379.20
18,176.20
932.70
-
575.10
Other Liabilities
10,048.70
804.60
562.00
5,791.10
-
Total Liabilities
27,789.60
68,201.60
33,921.50
29,658.10
9,313.20
Common Equity (Total)
62,542.40
58,514.70
23,713.40
4,883.80
50,508.00
Total Shareholders' Equity
62,542.50
58,514.80
23,713.50
24,283.90
50,508.10
Total Equity
62,026.40
58,073.80
23,283.80
23,466.50
50,189.80
Liabilities & Shareholders' Equity
89,816.10
126,275.40
57,205.30
53,514.40
63,375.70
Accumulated Minority Interest
516.00
441.00
429.70
817.40
318.30
Non-Equity Reserves
-
-
-
389.90
3,872.70
Preferred Stock (Carrying Value)
0.10
0.10
0.10
19,400.10
0.10
About Caladrius Biosciences
View Profile
